chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fast heartbeat all day; Cold sweats all over chest; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (Cold sweats all over chest), ASTHENIA (Weakness) and HEART RATE INCREASED (Fast heartbeat all day) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042l20a) for COVID-19 vaccination.     Concurrent medical conditions included Parkinson's disease.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced COLD SWEAT (Cold sweats all over chest) and ASTHENIA (Weakness). On 27-Jan-2021, the patient experienced HEART RATE INCREASED (Fast heartbeat all day). At the time of the report, COLD SWEAT (Cold sweats all over chest), ASTHENIA (Weakness) and HEART RATE INCREASED (Fast heartbeat all day) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product included blood thinner, blood pressure medication, Parkinson medication and cholesterol medication.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Reporter denied having email address or fax number.
Systemic: Confusion-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Hypertension-Medium, Systemic: Visual Changes/Disturbances-Medium, Additional Details: PT AND HUSBAND HAD WARNED THAT PT HAD SAME ADVERSE EVENT DURING 1ST AND 2ND PFIZER DOSES AND NOTHING DONE IN ER DURING EPISODE. SAID PER DR BENEFIT OUTWAY RISK  AND PT TYPICALLY RECOVER AFTER 4 HOURS OF LAYING IN THE BED. AT 4:25PM 2MINS AFTER SHOT PT BECAME VERY LETHARGIC, BUT AOX3, BP 162/107, HUSBAND SAID SIMILAR REACTION AS BEFORE. INSISTED BETTER TO TAKE PT HOME TO BED LIKE BEFORE. ASSISTED PT WALK X2 TO CAR. AT 6:24PM CALL SPOKE WITH HUSBAND SAID PT RECOVERING MUCH FASTER THAN BEFORE.
Patient immediately experienced bruising in the arm and pain the next day.    She has had complaints of arm soreness and a loss of range of motion.
This spontaneous report as received from a healthcare worker refers to a 8 week old patient of unknown gender. The patient's relevant medical history, current conditions and concomitant medications were not reported. On 12-NOV-2015 the patient was vaccinated with improperly stored ROTATEQ (dosing details were not reported) lot # L008053, with an expiry date of 30-NOV-2016, orally. The vaccine was administered at public health clinic or hospital with public funds. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Approx. 6 hours after vaccination fever & chills began - whole upper LA red and sore - dx cellulitis by Dr, received ceftriaxone and clindamycin.
This spontaneous report as received from a doctor of pharmacy refers to a female patient of unknown age. The patient was vaccinated subcutaneously in the right arm with ZOSTAVAX on 02-JUL-2012 (lot # and dose not reported). No other co-suspects and no concomitant medications were reported. On 09-JUL-2012 the patient developed a round, red area at the injection site, 8 days after onset of therapy. The patient called the pharmacy, no treatment was given for the reported event and no lab diagnostic tests were performed. The outcome of round red area the injection site was reported as not recovered. The relatedness for round red area at the injection site was not reported for ZOSTAVAX. Additional information has been requested.
sx started day p/vax h/a, fever 100, flu like sx;visit to MD office & on 2nd course of tx;
Moderna COVID?19 Vaccine  I experienced a low fever, chills, shakiness, muscle aches, insomnia, nausua, extreme fatigue, and pain/swelling at injection site. All symptoms were unrelieved by tylenol and ibuprofen. Symptoms began about 10hrs after vaccine administration and persisted for 24hrs. Headache lasted for about 48hrs.
Up to 50 patients given 1st or 2nd doses 1-45 days after vaccine had been stored in liquid state at appropriate temperature for 30 days; Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Up to 50 patients given 1st or 2nd doses 1-45 days after vaccine had been stored in liquid state at appropriate temperature for 30 days) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Up to 50 patients given 1st or 2nd doses 1-45 days after vaccine had been stored in liquid state at appropriate temperature for 30 days) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, PRODUCT STORAGE ERROR (Up to 50 patients given 1st or 2nd doses 1-45 days after vaccine had been stored in liquid state at appropriate temperature for 30 days) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Batch/Lot numbers provided for unknown patients were: .14 doses of lot# 047A21A 20May2021, 32 doses of lot # 009C21A 22 May2021, 20 doses of lot# 009C21A 25 May2021, 11 doses of lot# 009C21A 28 May2021, 6 doses of lot# 006B21A 11 Jun 2021, 1 dose of lot# 047A21A 23 Jun 2021, 3 doses of lot# 009C21A 10Jul 2021, 5 doses of lot# 006B21A 13Jul 2021  No concomitant medication was reported. No treatment was reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Follow-up information received on 23 Jul 2021: Updated iNarrative reference Batch numbers. On 02-Aug-2021: Follow-up information received on 03-Aug-2021, contains non-significant information.
Excessive crying at time of injections, 4:30 PM; excessive sleeping for the rest of the day and through the night (woke only to nurse), 5:00 PM through 10:00 AM on 05/08/2013; high fever (102.3), 12:00 PM on 05/08/2013.
COVID VAccine Breakthrough CAse  Moderna Dose 1 2/24/21 (013A21A) Moderna Dose 2 3/24/21 (003B21A) COVID Negative 11/20/21 COVID Positive 12/3/21  12/4/21: Patient is a pleasant 84-year-old female with past medical history multiple myeloma, back pain, history of PE, CKD stage IIIA, history of compression fracture T11 and L1 comes in with chief complaint fever weakness.  Patient is a poor historian history obtained from combination of chart review and ED provider sign-out.  Reportedly patient has been having weakness chronic back pain decreased functionality, and spiked fever of 102/103 as outpatient, family discussed with oncologist to recommended patient had to the emergency room for further evaluation.  Patient did received Tylenol prior to arrival.  On arrival in ED patient was afebrile. Chem panel without significant derangement, CBC improvement in leukopenia, was anemia with hemoglobin of 6.8 without any bleeding or bruising.  UA without pyuria, chest x-ray without acute derangement patient was well on room air.  ED administered 1 unit packed RBC, patient/family requesting possible placement. Request was made to admit patient to medical service for further treatment evaluation.  Patient seen evaluated at bedside lying comfortably in bed currently denies any lightheadedness, dizziness, vision change, no current chills or fever but has had episodes prior to arrival no shortness of breath chest pain palpitations abdominal pain, paresthesia or swelling of extremities.  Reports she does have periodic issues with urinary retention but no dysuria. Gets periodically constipated.  Denies any sick contacts or recent travel outside the area endorses compliance with medications.  Reportedly follows with oncologist.  Denies tobacco, alcohol, marijuana/recreational drug use, over-the-counter uses p.r.n. acetaminophen.  Family history otherwise reviewed and noncontributory to presenting problem.  Unclear on COVID-19 vaccination status booster with though documented received 2/2 earlier this year.  12/15/21: She will continue Lovenox injection at the nursing home for her history of PE.  Can be changed to oral anticoagulant NOAC, on discharge from skilled
Headache, dizziness  and brain fog initially. Significant arm, shoulder and neck pain on left side. (Injection site).  Neck pain continues after two days/seems worse.
Patient received vaccine on 11/12 at 3 P.M. After half an hour appeared fine left pharmacy. About 8 PM had fever of 103 degrees and rapid heart rate lasted 4 to 6 hrs. No hospital visit.
Headache; Chills; Hot flashes; Blurred vision; Tingling in hands; Nausea; Head feels fuzzy at times thinking takes a few moments/ Felt foggy when I woke up; Emotional; Slept alot first 2 days; My lungs seem sore; This is a spontaneous report received from a contactable reporter (consumer). The reporter is the patient.   A 55-year-old female patient (not pregnant) received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), administered in right arm, administration date 26Nov2021 at 14:00 (Batch/Lot number: unknown) at the age of 55 years as dose 1, single for COVID-19 immunisation. The patient's relevant medical history was not reported. The patient did not receive other medications within two weeks of vaccination. The following information was reported: HEADACHE (non-serious), CHILLS (non-serious), HOT FLUSH (non-serious), VISION BLURRED (non-serious), PARAESTHESIA (non-serious), NAUSEA (non-serious), FEELING ABNORMAL (non-serious), EMOTIONAL DISORDER (non-serious), PULMONARY PAIN (non-serious), all with onset 26Nov2021, outcome "recovering", described as "headache, chills, hot flashes, blurred vision, tingling in hands, nausea, head felt fuzzy at times thinking took a few moments, emotional, felt foggy when she woke up, lungs seemed sore"; HYPERSOMNIA (non-serious) with onset 26Nov2021, outcome "recovered" (28Nov2021), described as "slept a lot first 2 days". The events "headache, chills, hot flashes, blurred vision, tingling in hands, nausea, head felt fuzzy at times thinking took a few moments, emotional, slept a lot first 2 days, felt foggy when she woke up, lungs seemed sore" were evaluated at the physician office visit. Therapeutic measures were taken as a result of headache, chills, hot flush, vision blurred, paraesthesia, nausea, feeling abnormal, emotional disorder, hypersomnia and pulmonary pain.  Additional Information: The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19.  The lot number for BNT162b2 was not provided and will be requested during follow up.
This spontaneous report was received from a 65 year old female speech pathologist with allergy to penicillin referring on herself. Patient had no pertinent medical history. On 11-NOV-2013, the patient was vaccinated with ZOSTAVAX VIAL 19400 PFU (dose, route and lot number were not reported). Concomitant therapies included VAGIFEM and EVISTA. On 12-NOV-2013, the patient developed a red, raised area at the injection site following the administration of ZOSTAVAX. No treatment was given for the adverse event, no laboratory diagnostics studies were performed. The outcome of red, raised area at the injection site was reported as recovering. Additional information has been requested.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 11-Feb-2021, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
1.5 days later - fever of 102.4, altered mental status, weakness, tachycardia (115), tachypnea (28), sent to acute care hospital given acetaminophen and supportive care, resolved in 2 days time
Swelling and redness at arm where DTaP and IPV were given. Swelling is from shoulder to elbow according to mom.
Narrative:  93yo male patient died at home on 12/22/2021 with heart failure (recent ER visit to nonfacility hospital): Patient self-presented to community emergency facility Emergency Notification Intake Date Presenting to the Facility: 12/3/2021 Hospital Name: Hospital Chief complaint: Heart Failure PAST MEDICAL HISTORY Bladder cancer (SCT 399326009) Urinary bladder stone (SCT 70650003) Onychomycosis of toenails (SCT 403059006Onychomycosis of toenails (SCT 403059006) Debility (SCT 13791008) Benign prostatic hyperplasia (SCT 266569009) Chronic viral hepatitis B without delta-Peripheral neuropathy (SCT 302226006) History of non-Hodgkins lymphoma (SCT 42 Pt had received covid vaccines on 2/26/21 & 3/26/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time for vaccine administration.
Internal itching on extremities mainly arms hands and face. Sometimes feet and legs.; This is a spontaneous report from a contactable consumer (patient). A 38-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in arm right on 05Sep2021 (at the age of 38-year-old) as dose 1, single for COVID-19 immunisation. Medical history included Factor V, PCOS, Type 2 Diabetes. Concomitant medication included clonazepam (KLONOPIN) and metformin taken for an unspecified indication. Patient had no known allergies and no past drug event. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. On 05Sep2021 the patient experienced internal itching on extremities mainly arms hands and face, sometimes feet and legs. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Patient received treatment for the event with Zyrtec (once a day). Since the vaccination the patient was not tested for COVID-19. Outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pain in R arm, wrist, forearm 4 days after shot administered - Given pain/anti-inflammatory med and labs done.
Red and swollen arm.  She went back to store and staff gave her Benadryl, 25 mg orally.  The event resolved.
Started 5/17/2021, had sinus pressure, light headed, felt faint, this lasted a couple of days and then I felt better and then started feeling the same issues on 5/22/2021, but with added heart fluttering feeling, went to Urgent Care and they determined it was an ear infection and put me on azithromycin and Mucinex. Started feeling better until end of June 2021, went to my primary care doctor on 7/2/2021, they also said it was an ear infection, gave me more azithromycin and Sudafed 30MG, felt better for a couple of weeks and started having the same symptoms again but more intense on the light headed, heart flutter and feeling faint. Went to the doctor again on 7/22/2021, increased Sudafed to 120MG ER and flonase made the heart flutter worse and added an anxiety feeling, I stopped taking the Sudafed and flonase. Went to the Ear Nose and Throat doctor 8/26/2021, indicated sinuses slightly inflamed, no issues with throat or ears. He ordered a CT scan. Felt worse on 8/29/21 with the anxiety feeling, went to the Emergency Room they took blood, also my vitals showed my blood pressure at 187/103 (not normal for me), they did a quick EKG which came back normal, put me on a heart monitor for 14 days (results pending). I have a follow up with the Ear Nose and Throat doctor on 9/16/2021. It is unknow of these issues are related to the vaccine or not, that has not been determined.
At 6pm patient's tongue was numb and the left side of their face was tingling. Patient felt like she had burnt her tongue and was trying to taste with it still.  Around 11pm the numbness started to go away and she could taste things better.  Today everything is pretty much normal.
fever 103.4, fussy 24AUG93 dx rt ear infect 2 days p/shots 24AUG93;
pt recvd vax & pt exp a sore arm, h/a, & vomiting following vax w/Hep B; pt recovered; No further details were provided;
Patient reported pain at site of injection (right deltoid) with radiation down the right arm and subsequent swelling of the right hand.
Throbbing pain in tricep and spread into lat area. Felt feverish and tired. Administered two Tylenol Extra Strength about 18:00. Felt better. Woke up about 1:45AM shivering and feeling feverish. Took oral temperature and got 100.2 Administered 400mg Ibuprofen 02:00.
I just had a sore throat and a little fatigue. I tested positive for COVID-19 and called a doctor and they prescribed me Paxlovid. I think the Paxlovid kept my symptoms from getting worse.
Pt developed chickenpox that consisted of 200 lesions that were described as painful and itchy.
The patient called the pharmacy to discuss the side effects of the Shingles vaccine. She said she had received the vaccine the previous day and was experiencing more pain than she had anticipated. The next day, she returned to the pharmacy to buy liquid bandages and asked for a recommendation. After providing her with one, she proceeded to show the red area surrounding the injection site of her vaccine. She also stated that if she lifted her arm above a certain level, she experienced pain even though she takes prescription pain medications. She was advised to see her doctor for further assessment and a follow up call was made today to see if her symptoms had improved. She stated that she felt much better today and decided not to see her doctor.
vaccine was administered subcutaneously rather than the recommended intramuscular route, pt did not report any adverse effect
Skin rash, itching to bilateral thighs, bilateral extremities, and bilateral upper hemi-thorax.
pt recvd vax; PC from mom stating pt had an allergic rxn on noc of shot;broke out in rash & ran fever of 105.9;was seen by MD at er, MD said it was a rxn;
I had intense body aches and fatigue for the next 2 days. I started to feel better again. Then the next night I had migraines light sensitivity, nausea, and loss of appetite. I starting vomiting and I talked to my doctor for stronger nausea medication. My migraines started getting better. I went to eat breakfast one day and I was really quakey and shaky. I thought it was because I wasn't eating but this lasted for 4 to 5 days.
The child had vomiting within hours of admin. Had fever assoc with cold in 1 wk. Developed I.T.P. within 2 weeks (5/25/11). She also was exposed to pesticides during this time.
Information has been received from a pharmacist concerning an 82 year old female who was vaccinated with a dose of ZOSTAVAX.  Subsequently the patient developed shingles.  Unspecified medical attention was sought.  A product quality complaint was not involved.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 3/26/2008. Initial and follow up information has been received from a pharmacist concerning a 72 year old female (also reported as 82) with microscopic colitis who in the AM of 19-NOV-2003 was vaccinated into the left deltoid with a first dose of 0.5 ml of ZOSTAVAX (Merck) (lot# 658082/0744U). On 24 JAN 2008 the patient developed acute shingles, with vesicles at the left neck, shoulder and C4 dermatome, greater than 20 lesions. The patient experienced pain on a scale of 1 to 10, at a level of 9 to 10. Other systemic symptoms reported included neck pain. There was no illness at the time of vaccination. There was no recent exposure to chickenpox or herpes zoster. No lab diagnostic studies were performed, and no specimen was collected for PCR. Unspecified medical attention was sought. There was no product quality complaint. At the time of reporting the patients outcome as unknown, the patient left the state shortly after onset. Additional information is not expected.
Information has been received from a physician concerning a 13 month old female, with a history of a liver transplant in May 2005, and who had no allergies, who on 11/30/05 was vaccinated once with an IM 0.5ml dose of MMR. Concomitant vaccine administered on the same day included a 0.5ml SC dose of varicella virus vaccine live. Concomitant therapy included tacrolimus, sulfamethoxazole/trimethoprim, lansoprazole, ursodiol, nystatin, vitamins, sirolimus, and lamivudine. The patient's liver function test was done on 5/1/06 and the patient received 517 glutamic-oxaloacetic transaminase and 451 glutamic-pyruvic transaminase. The test was performed again on 5/31/06 and the patient received 229 glutamic-oxaloacetic transaminase and 242 glutamic pyruvic transaminase. The last test was performed on 6/6/06 and the patient received 199 glutamic oxaloacetic transaminase and 225 glutamic-pyruvic transaminase. The patient was noted to be recovering. It was noted that other than elevated liver function test the patient had no symptoms such as fever, diarrhea, or jaundice. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. The patient's alanine aminotransferase increase was considered to be an other important medical event (OMIC). Additional information has been requested.
(L) upper arm red, inflamed hot to touch and swollen extends down to elbow.
Medication deviation. Patient was to receive 2nd dose of Moderna vaccine, but was administered Pfizer.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient was between the age of 10 and 18 years. Pertinent medical history and drug reactions or allergies were not specified. On 14-APR-2014, the patient was vaccinated with a dose of GARDASIL (dose in series unspecified) 0.5 mL, once, intramuscularly, lot number J006850, expiry date 31-MAR-2016 or J011272, expiry date 21-APR-2016, that was exposed to 30 Fahrenheit (F) for 10 minutes on 06-MAR-2014. No adverse effects were reported. This is one of several reports received from the same reporter (linked to MARRS # 1405USA008203, 1405USA0082972, 1405USA008973, 1405USA008974, 1405USA008975, 1405USA008976, 1405USA008977, 1405USA008978, 1405USA008980, 1405USA008981, 1405USA008982). Additional information has been requested.
Severe arm pain within 4 hrs. I was grossly bedridden (all severe reactions x 10) headache severe plus all flu symptoms severe bedridden up and about 1 1/2 days then very severe pain body.
Diarrhea/severe cramps overnight the next day (6-7 loose stools), treated with one dose of Imodium with some improvement. Resolved after 12hours. Severe fatigue and chills lasting 24hrs and resolved without any treatment.
Had achy muscles, cough and dizziness. Went to hospital; had pneumonia. Hospitalized 11/18 for 7 days. Discharge summary states short of breath, fever. msv